![[Industry Direct] PHI Studio & Agog Are Seeking Immersive Artists for a Four Week Residency Program](https://roadtovrlive-5ea0.kxcdn.com/wp-content/uploads/2025/05/phi-immersive-residency-2-341x220.jpg?#)
PTC's Huntington’s study succeeds, but accelerated approval uncertain
PTC Therapeutics announced Monday that its splicing drug for Huntington’s disease met the primary endpoint of a Phase 2 study, but stopped short of spelling out the important data that could ...
PTC Therapeutics announced Monday that its splicing drug for Huntington’s disease met the primary endpoint of a Phase 2 study, but stopped short of spelling out the important data that could ...
